Impact of COVID-19 on the clinical course of nephrotic syndrome in children: a single-center study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Children with nephrotic syndrome may experience disease relapse or aggravation triggered by various viral infections. Limited studies on the clinical implications of the coronavirus disease 2019 (COVID-19) pandemic in children with nephrotic syndrome have been published worldwide. Therefore, this study aimed to investigate the effects of COVID-19 on the clinical course of nephrotic syndrome in children. Methods: The medical records of 59 patients with idiopathic nephrotic syndrome who visited our hospital between February and June 2022 were retrospectively analyzed. Results: Twenty of the total 59 patients with nephrotic syndrome were diagnosed with COVID-19 during the study period. The mean age at the time of the diagnosis of nephrotic syndrome and COVID-19 in all 20 patients was 4.6±3.5 and 8.9±3.9 years, respectively. Three patients (15%) were diagnosed with nephrotic syndrome relapse during COVID-19 and the relapse rate was similar to them without COVID-19 (20.5%, 8/39 patients). At the time of the COVID-19 diagnosis, fever (85%) and cough (40%) were the most common symptoms. After the diagnosis of COVID-19, all patients showed improvement with symptomatic treatment, including antipyretic analgesics and cold medicine. None of the critical patients required hospitalization or oral antiviral medications. Conclusions: Despite the use of immunosuppressants, the clinical manifestations of COVID-19 in children with nephrotic syn- drome were not severe and are expected to be similar to that in the general population. The relapse rate of nephrotic syndrome in children with COVID-19 was also not different from them without COVID-19.
Abstract
Purpose: Children with nephrotic syndrome may experience disease relapse or aggravation triggered by various viral infections. Limited studies on the clinical implications of the coronavirus disease 2019 (COVID-19) pandemic in children with nephrotic syndrome have been published worldwide. Therefore, this study aimed to investigate the effects of COVID-19 on the clinical course of nephrotic syndrome in children. Methods: The medical records of 59 patients with idiopathic nephrotic syndrome who visited our hospital between February and June 2022 were retrospectively analyzed. Results: Twenty of the total 59 patients with nephrotic syndrome were diagnosed with COVID-19 during the study period. The mean age at the time of the diagnosis of nephrotic syndrome and COVID-19 in all 20 patients was 4.6±3.5 and 8.9±3.9 years, respectively. Three patients (15%) were diagnosed with nephrotic syndrome relapse during COVID-19 and the relapse rate was similar to them without COVID-19 (20.5%, 8/39 patients). At the time of the COVID-19 diagnosis, fever (85%) and cough (40%) were the most common symptoms. After the diagnosis of COVID-19, all patients showed improvement with symptomatic treatment, including antipyretic analgesics and cold medicine. None of the critical patients required hospitalization or oral antiviral medications. Conclusions: Despite the use of immunosuppressants, the clinical manifestations of COVID-19 in children with nephrotic syn- drome were not severe and are expected to be similar to that in the general population. The relapse rate of nephrotic syndrome in children with COVID-19 was also not different from them without COVID-19.
참고문헌 (27)
- "Coronavirus (COVID-19)" (2022)[URL]
- Lebedev L, "Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine", Am J Kidney Dis, 78, pp.142~145 (2021)
- Klomjit N, "COVID-19 vaccination and glomerulonephritis", Kidney Int Rep, 6, pp.2969~2978 (2021)
- Kudose S, "Kidney biopsy findings in patients with COVID-19", J Am Soc Nephrol, 31, pp.1959~1968 (2020)
- Batlle D, "Acute kidney injury in COVID-19 : emerging evidence of a distinct pathophysiology", J Am Soc Nephrol, 31, pp.1380~1383 (2020)
- Bomback AS, "De novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far?", Am J Kidney Dis, 78, pp.477~480 (2021)
- Bjornstad EC, "Preliminary assessment of acute kidney injury in critically ill children associated with SARS-CoV-2 infection : a multicenter cross-sectional analysis", Clin J Am Soc Nephrol, 16, pp.446~448 (2021)
- Serafinelli J, "Kidney involvement and histological findings in two pediatric COVID-19 patients", Pediatr Nephrol, 36, pp.3789~3793 (2021)
- Hanna C, "IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine", Kidney Int, 100, pp.705~706 (2021)
- Kim L, "Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19: COVIDNET, 14 States, March 1-July 25, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1081~1088 (2020)
- de Souza TH, "Clinical manifestations of children with COVID-19 : a systematic review", Pediatr Pulmonol, 55, pp.1892~1899 (2020)
- Badal S, "Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: a systematic review and meta-analysis", J Clin Virol, 135, pp.104715~ (2021)
- Parcha V, "A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States", Sci Rep, 11, pp.10231~ (2021)
- Valverde I, "Acute cardiovascular manifestations in 286children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe", Circulation, 143, pp.21~32 (2021)
- Gupta A, "Extrapulmonary manifestations of COVID-19", Nat Med, 26, pp.1017~1032 (2020)
- Basalely A, "Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19", Kidney Int, 100, pp.138~145 (2021)
- Shah SA, "New-onset nephrotic syndrome in a child associated with COVID-19 infection", Front Pediatr, 8, pp.471~ (2020)
- Alvarado A, "COVID-19associated with onset nephrotic syndrome in a pediatric patient:coincidence or related conditions?", Pediatr Nephrol, 36, pp.205~207 (2021)
- MacDonald NE, "Role of respiratory viruses in exacerbations of primary nephrotic syndrome", J Pediatr, 108, pp.378~382 (1986)
- Uwaezuoke SN, "Steroid-sensitive nephrotic syndrome in children : triggers of relapse and evolving hypotheses on pathogenesis", Ital J Pediatr, 41, pp.19~ (2015)
- Zhang H, "New insight into the pathogenesis of minimal change nephrotic syndrome : role of the persistence of respiratory tract virus in immune disorders", Autoimmun Rev, 15, pp.632~637 (2016)
- Crane C, "Rates of idiopathic childhood nephrotic syndrome relapse are lower during the COVID-19 pandemic", Pediatr Nephrol, 37, pp.2679~2685 (2022)
- Morello W, "COVID-19 and idiopathic nephrotic syndrome in children : systematic review of the literature and recommendations from a highly affected area", Pediatr Nephrol, 37, pp.757~764 (2022)
- Angeletti A, "COVID-19 in children with nephrotic syndrome on anti-CD20 chronic immunosuppression", Clin J Am Soc Nephrol, 15, pp.1494~1495 (2020)
- Marlais M, "COVID-19 in children treated with immunosuppressive medication for kidney diseases", Arch Dis Child, 106, pp.798~801 (2020)
- Sinha R, "Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome", Pediatr Res, 92, pp.3~5 (2022)
- Angeletti A, "An update on COVID-19 in paediatric and young adults with nephrotic syndrome, receiving chronic immunosuppression during the Omicron pandemic", J Nephrol, 35, pp.1775~1776 (2022)